The new guidelines rank treatment options using data from 69 experts, recommending cognitive-behavioral therapy (CBT) as the primary first-line treatment. The guidelines also suggest starting medication before adding CBT for severe patients, and recommend a trial of clomipramine after failed SSRI trials.
Researchers at Harvard Medical School have discovered a novel group of compounds without nitrogen that recognize the same molecular targets as common drugs, including Prozac and Ritalin. These experimental compounds appear to be as powerful as their traditional counterparts.
In a groundbreaking study, antidepressant Zoloft significantly reduced depression, anxiety, insomnia, and reexperiencing of trauma in rape victims with chronic PTSD. Four out of five women participating in the study responded positively to treatment after 12 weeks on Zoloft.